A. Matsumoto

发表

Modulation of Pulsatile Gonadotropin Secretion by Testosterone in Man

A. Matsumoto, W. Bremner, 1984 .

Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men.

A. Iranmanesh, A. Dobs, R. Swerdloff, 2000, Journal of Clinical Endocrinology and Metabolism.

The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men.

A. Araujo, J. Mckinlay, A. Matsumoto, 2009, The Journal of clinical endocrinology and metabolism.

Dopamine Production in the Caudate Putamen Restores Feeding in Dopamine-Deficient Mice

R. Palmiter, A. Matsumoto, M. Szczypka, 2001, Neuron.

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

Ali Iranmanesh, Laura Hull, Nancy Berman, 2004, The Journal of clinical endocrinology and metabolism.

Low testosterone levels predict incident depressive illness in older men: effects of age and medical morbidity.

D. Kivlahan, A. Matsumoto, V. Moceri, 2005, The Journal of clinical psychiatry.

Feeding behavior in dopamine-deficient mice.

R. Palmiter, W. Alaynick, A. Matsumoto, 1999, Proceedings of the National Academy of Sciences of the United States of America.

A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer

P. Kantoff, M. Bhasin, G. Bubley, 2016, Clinical Cancer Research.

Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated with low-dose human chorionic gonadotropin: a randomized, controlled trial.

A. Matsumoto, W. Bremner, B. Marck, 2013, Fertility and sterility.

Testosterone administration inhibits gonadotropin secretion by an effect directly on the human pituitary.

A. Matsumoto, W. Bremner, C. B. Sheckter, 1989, The Journal of clinical endocrinology and metabolism.

Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction.

A. Mcneilly, A. Matsumoto, W. Bremner, 1996, The Journal of clinical endocrinology and metabolism.

Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels.

A. Matsumoto, C. Wilkinson, S. Yellon, 1999, Endocrinology.

Ganglioneuromas and renal anomalies are induced by activated RETMEN2B in transgenic mice

R. Palmiter, A. Matsumoto, R. Kapur, 1999, Oncogene.

Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study.

P. Schellhammer, C. Roehrborn, M. Resnick, 2000, The Journal of urology.

Intraindividual variation in levels of serum testosterone and other reproductive and adrenal hormones in men

J. Mckinlay, A. Matsumoto, D. Brambilla, 2007, Clinical endocrinology.

Diagnosis and Evaluation of Hypogonadism.

A. Matsumoto, 2022, Endocrinology and metabolism clinics of North America.

Use of Hormone Testing for the Diagnosis and Evaluation of Male Hypogonadism and Monitoring of Testosterone Therapy: Application of Hormone Testing Guideline Recommendations in Clinical Practice.

X. Zhang, A. Matsumoto, D. Muram, 2015, The journal of sexual medicine.

Testosterone administration in older men.

A. Matsumoto, 2013, Endocrinology and metabolism clinics of North America.

The therapeutic potential of testosterone patches.

A. Matsumoto, J. Amory, 1998, Expert opinion on investigational drugs.

Short-Term Estrogen Withdrawal Increases Adiposity in Healthy Men.

A. Matsumoto, J. Amory, S. Page, 2016, The Journal of clinical endocrinology and metabolism.

Dutasteride reduces prostate size and prostate specific antigen in older hypogonadal men with benign prostatic hyperplasia undergoing testosterone replacement therapy.

A. Matsumoto, M. Dighe, B. Marck, 2011, The Journal of urology.

The effect of 5alpha-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young men.

Christina Wang, R. Swerdloff, A. Matsumoto, 2008, The Journal of urology.

Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.

A. Matsumoto, W. Bremner, C. A. Paulsen, 1996, The Journal of clinical endocrinology and metabolism.

Oral testosterone with and without concomitant inhibition of 5α-reductase by dutasteride in hypogonadal men for 28 days.

Christina Wang, R. Swerdloff, A. Matsumoto, 2011, The Journal of urology.

Testosterone administration suppresses adiponectin levels in men.

K. Herbst, A. Matsumoto, W. Bremner, 2005, Journal of andrology.

Masculine vitality: pros and cons of testosterone in treating the andropause.

H. Fillit, S. Asthana, J. Morley, 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone.

N. Watts, Kirk A Easley, A. Matsumoto, 2004, The Journal of clinical endocrinology and metabolism.

Testosterone release from a subcutaneous, biodegradable microcapsule formulation (Viatrel) in hypogonadal men.

A. Matsumoto, J. Amory, B. Anawalt, 2002, Journal of andrology.

DHEA and testosterone in the elderly.

A. Matsumoto, W. Bremner, S. Page, 2007, The New England journal of medicine.

Testosterone treatment and mortality in men with low testosterone levels.

N. Smith, A. Matsumoto, M. Shores, 2012, The Journal of clinical endocrinology and metabolism.

Workshop on normal reference ranges for estradiol in postmenopausal women, September 2019, Chicago, Illinois.

R. Santen, S. Davis, A. Matsumoto, 2020, Menopause.

Cross‐sectional association of endogenous steroid hormone, sex hormone‐binding globulin, and precursor steroid levels with hemostatic factor levels in postmenopausal women

A. LaCroix, B. Psaty, S. Heckbert, 2017, Journal of thrombosis and haemostasis : JTH.

Implementation of a fall screening program in a high risk of fracture population

E. Phelan, J. Shofer, A. Matsumoto, 2017, Archives of Osteoporosis.

Prostate Specific Antigen Levels during Testosterone Treatment of Hypogonadal Older Men: Data from a Controlled Trial.

C. Lewis, T. Gill, J. Cauley, 2019, The Journal of clinical endocrinology and metabolism.

Immature spermatids are not prevalent in semen from men who are receiving androgen-based contraceptive regimens.

Y. Zhengwei, R. Mclachlan, A. Matsumoto, 1998, Fertility and sterility.

Fundamental aspects of hypogonadism in the aging male.

A. Matsumoto, 2003, Reviews in urology.

Hypothalamic gliosis by MRI and visceral fat mass negatively correlate with plasma testosterone concentrations in healthy men

A. Matsumoto, B. Marck, E. Schur, 2018, Obesity.

Neoadjuvant Enzalutamide Prior to Prostatectomy

P. Kantoff, P. Nelson, G. Haas, 2016, Clinical Cancer Research.

Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men.

J. Heiman, A. Matsumoto, W. Bremner, 1994, The Journal of clinical endocrinology and metabolism.

Effect of medical castration on CD4+ CD25+ T cells, CD8+ T cell IFN-gamma expression, and NK cells: a physiological role for testosterone and/or its metabolites.

P. Nelson, S. Plymate, D. Lin, 2006, American journal of physiology. Endocrinology and metabolism.

Follicle-stimulating hormone and human spermatogenesis.

A. Matsumoto, W. Bremner, C. A. Paulsen, 1981, The Journal of clinical investigation.

Human chorionic gonadotropin and testicular function: stimulation of testosterone, testosterone precursors, and sperm production despite high estradiol levels.

R. Rebar, A. Matsumoto, W. Bremner, 1983, The Journal of clinical endocrinology and metabolism.

Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors.

P. Nelson, G. Bubley, S. Balk, 2011, Cancer research.

Preoperative Supraphysiological Testosterone in Older Men Undergoing Knee Replacement Surgery

K. Chansky, A. Matsumoto, W. Bremner, 2002, Journal of the American Geriatrics Society.

Longitudinal changes in plasma sex hormone concentrations correlate with changes in CT‐measured regional adiposity among Japanese American men over 10 years

E. Boyko, D. Leonetti, W. Fujimoto, 2020, Clinical endocrinology.

Baseline estradiol concentration in community-dwelling Japanese American men is not associated with intra-abdominal fat accumulation over 10 years.

E. Boyko, D. Leonetti, W. Fujimoto, 2016, Obesity research & clinical practice.

SARCOPENIA: AN ENDOCRINE DISORDER?

A. Vinik, J. Morley, A. Matsumoto, 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Stable Intraprostatic Dihydrotestosterone in Healthy Medically Castrate Men Treated With Exogenous Testosterone.

J. Wright, D. Lin, A. Matsumoto, 2016, The Journal of clinical endocrinology and metabolism.

Recent trends in testosterone testing, low testosterone levels, and testosterone treatment among Veterans

S. Heckbert, A. Matsumoto, S. Zeliadt, 2015, Andrology.

The association of obesity with sex hormone‐binding globulin is stronger than the association with ageing – implications for the interpretation of total testosterone measurements

A. Matsumoto, J. Amory, S. Page, 2015, Clinical endocrinology.

Testosterone, aging and survival: biomarker or deficiency

A. Matsumoto, M. Shores, 2014, Current opinion in endocrinology, diabetes, and obesity.

Performance of total testosterone measurement to predict free testosterone for the biochemical evaluation of male hypogonadism.

J. Hotaling, A. Matsumoto, T. Walsh, 2012, The Journal of urology.

Testosterone (T)-induced changes in arcuate nucleus cocaine-amphetamine-regulated transcript and NPY mRNA are attenuated in old compared to young male brown Norway rats: contribution of T to age-related changes in cocaine-amphetamine-regulated transcript and NPY gene expression.

A. Matsumoto, T. Wolden‐Hanson, Elliott H. Sohn, 2002, Endocrinology.

expression, and NK cells: a physiological role for testosterone and/or its metabolites

P. Nelson, S. Plymate, D. Lin, 2006 .

Differential control of luteinizing hormone and follicle-stimulating hormone secretion by luteinizing hormone-releasing hormone pulse frequency in man.

A. Matsumoto, W. Bremner, K. M. Gross, 1987, The Journal of clinical endocrinology and metabolism.

Association of Tissue Abiraterone Levels and SLCO Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer

M. Loda, P. Nelson, L. True, 2017, Clinical Cancer Research.

Daily Melatonin Administration at Middle Age Suppresses Male Rate Visceral Fat, Plasma Leptin, and Plasma Insulin to Youthful Levels.

A. Matsumoto, C. Wilkinson, S. Yellon, 1999, Endocrinology.

Fasting-induced increases in food intake and neuropeptide Y gene expression are attenuated in aging male brown Norway rats.

A. Matsumoto, D. Gruenewald, B. Marck, 1996, Endocrinology.

Food intake and estradiol effects on insulin binding in brain and liver

M. Schwartz, A. Matsumoto, D. Baskin, 1993, Physiology & Behavior.

Androgen synthesis in the gonadotropin-suppressed human testes can be markedly suppressed by ketoconazole.

A. Matsumoto, W. Bremner, B. Marck, 2013, The Journal of clinical endocrinology and metabolism.

The effect of gonadotropin withdrawal and stimulation with human chorionic gonadotropin on intratesticular androstenedione and DHEA in normal men.

A. Matsumoto, W. Bremner, B. Marck, 2011, The Journal of clinical endocrinology and metabolism.

Serum LH correlates highly with intratesticular steroid levels in normal men.

A. Matsumoto, W. Bremner, J. Amory, 2010, Journal of andrology.

Dose-dependent increase in intratesticular testosterone by very low-dose human chorionic gonadotropin in normal men with experimental gonadotropin deficiency.

A. Matsumoto, W. Bremner, B. Marck, 2010, The Journal of clinical endocrinology and metabolism.

Intratesticular androgens and spermatogenesis during severe gonadotropin suppression induced by male hormonal contraceptive treatment.

A. Matsumoto, W. Bremner, J. Amory, 2007, Journal of andrology.

Elevated end-of-treatment serum INSL3 is associated with failure to completely suppress spermatogenesis in men receiving male hormonal contraception.

A. Matsumoto, W. Bremner, A. Coviello, 2007, Journal of andrology.

Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression.

K. Herbst, B. Zirkin, T. Brown, 2005, The Journal of clinical endocrinology and metabolism.

Suppression Testosterone in Normal Men with Testosterone-Induced Gonadotropin Low-Dose Human Chorionic Gonadotropin Maintains Intratesticular

K. Herbst, B. Zirkin, T. Brown, 2005 .

Intratesticular testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen.

K. Herbst, B. Zirkin, T. Brown, 2004, Journal of andrology.

A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management

A. Matsumoto, M. Grossmann, 2017, The Journal of clinical endocrinology and metabolism.

Serum bioactive and immunoreactive follicle-stimulating hormone levels and the response to clomiphene in healthy young and elderly men.

A. Hsueh, A. Matsumoto, W. Bremner, 1987, The Journal of clinical endocrinology and metabolism.

The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone.

K. Herbst, A. Matsumoto, W. Bremner, 2003, The Journal of clinical endocrinology and metabolism.

Androgen Treatment of the Hypogonadal Male

A. Matsumoto, 2003 .

Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men.

A. Iranmanesh, A. Dobs, R. Swerdloff, 2000, The Journal of clinical endocrinology and metabolism.

Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist.

A. Matsumoto, W. Bremner, M. Irwig, 2006, The Journal of clinical endocrinology and metabolism.

Increased hypothalamic melanin concentrating hormone gene expression during energy restriction involves a melanocortin-independent, estrogen-sensitive mechanism

M. Schwartz, A. Matsumoto, G. Morton, 2004, Peptides.

Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men

A. Iranmanesh, A. Dobs, R. Swerdloff, 2001, Clinical endocrinology.

Cognitive Function After Testosterone Treatment.

S. Resnick, A. Stephens-Shields, A. Matsumoto, 2017, JAMA.

Testosterone accumulation in prostate cancer cells is enhanced by facilitated diffusion

L. FitzGerald, L. True, E. Davicioni, 2019, The Prostate.

Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia.

J. Waldstreicher, A. Matsumoto, J. Rajfer, 2003, Urology.

The Long-Term Effect Of Specific Type II 5α-Reductase Inhibition With Finasteride on Bone Mineral Density in Men: Results of a 4-Year Placebo Controlled Trial

D. Kadmon, J. Waldstreicher, M. McClung, 2002 .

Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer

S. Balk, P. Kantoff, Heather H. Cheng, 2021, Clinical Cancer Research.

Contribution of Adrenal Glands to Intratumor Androgens and Growth of Castration-Resistant Prostate Cancer

P. Nelson, L. True, M. Tretiakova, 2018, Clinical Cancer Research.

Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man.

A. Matsumoto, W. Bremner, A. Karpas, 1986, The Journal of clinical endocrinology and metabolism.

Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.

A. Matsumoto, A. M. Matsumoto, 1990, The Journal of clinical endocrinology and metabolism.

The Effect of 5α-Reductase Inhibition with Dutasteride and Finasteride on Semen Parameters and Serum Hormones in Healthy Men

Christina Wang, R. Swerdloff, A. Matsumoto, 2007 .

Dose‐response effects of sex hormone concentrations on body composition and adipokines in medically castrated healthy men administered graded doses of testosterone gel

A. Matsumoto, B. Marck, J. Amory, 2017, Clinical endocrinology.

The Effect of Testosterone on Cardiovascular Biomarkers in the Testosterone Trials

M. Budoff, C. Lewis, T. Gill, 2018, The Journal of clinical endocrinology and metabolism.

Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression.

K. Herbst, A. Matsumoto, W. Bremner, 2000, Fertility and sterility.

A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations.

A. Matsumoto, W. Bremner, B. Anawalt, 1999, Journal of andrology.

Serum Testosterone (T) Level Variability in T Gel-Treated Older Hypogonadal Men: Treatment Monitoring Implications.

T. Gill, M. Pahor, S. Bhasin, 2015, The Journal of clinical endocrinology and metabolism.

Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.

A. Matsumoto, W. Bremner, J. Rivier, 1993, The Journal of clinical endocrinology and metabolism.

Persistent intraprostatic androgen concentrations after medical castration in healthy men.

P. Nelson, L. True, D. Lin, 2006, The Journal of clinical endocrinology and metabolism.

Reproductive endocrinology: Estrogens—not just female hormones

A. Matsumoto, 2013, Nature Reviews Endocrinology.

Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia.

J. Imperato-McGinley, J. Waldstreicher, A. Matsumoto, 2002, Urology.

A. Matsumoto, D. Gruenewald, 1991, Neurobiology of Aging.

Reduction of insulin binding in the arcuate nucleus of the rat hypothalamus after 6-hydroxydopamine treatment

D. Dorsa, A. Matsumoto, D. Baskin, 1989, Brain Research.

Androgens and estrogens predict sexual function after autologous hematopoietic stem cell transplant in men

A. Matsumoto, S. Graf, Lindsey J. Anderson, 2021, Andrology.

Validity and Clinically Meaningful Changes in the Psychosexual Daily Questionnaire and Derogatis Interview for Sexual Function Assessment: Results From the Testosterone Trials.

T. Gill, D. Cella, L. Derogatis, 2018, The journal of sexual medicine.

Large divergence in testosterone concentrations between men and women: Frame of reference for elite athletes in sex‐specific competition in sports, a narrative review

Frederick C W Wu, Christina Wang, R. Swerdloff, 2018, Clinical endocrinology.

Short-term pharmacokinetic comparison of a novel testosterone buccal system and a testosterone gel in testosterone deficient men

A. Dobs, Christina Wang, A. Matsumoto, 2004, Current medical research and opinion.

Doping Status of DHEA Treatment for Female Athletes with Adrenal Insufficiency

David Handelsman, A. Matsumoto, D. Gerrard, 2017, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.

57 – Hypothalamic Changes Relevant to Reproduction in Aging Male Rodents

A. Matsumoto, D. Gruenewald, 2001 .

Aging and the neuroendocrine regulation of reproduction and body weight

A. Matsumoto, D. Gruenewald, B. Marck, 2000, Experimental Gerontology.

The long-term effect of specific type II 5alpha-reductase inhibition with finasteride on bone mineral density in men: results of a 4-year placebo controlled trial.

D. Kadmon, J. Waldstreicher, M. McClung, 2002, The Journal of urology.

OBSTRUCTIVE SLEEP APNEA INDUCED BY TESTOSTERONE ADMINISTRATION

Kathryn A. Lee, D. Pierson, E. Giblin, 1983 .

Maximal testosterone suppression in prostate cancer--free vs total testosterone.

E. Crawford, G. Andriole, P. Lange, 2014, Urology.

Long-term administration of testosterone enanthate to normal men: Alterations of the urinary profile of androgen metabolites potentially useful for detection of testosterone misuse in sport

A. Matsumoto, L. Dehennin, 1993, The Journal of Steroid Biochemistry and Molecular Biology.

Circulating Androgen Concentrations and Risk of Incident Heart Failure in Older Men: The Cardiovascular Health Study

J. Gottdiener, C. Hirsch, N. Smith, 2022, Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.

Is high dosage testosterone an effective male contraceptive agent?

A. Matsumoto, 1988, Fertility and sterility.

Hypothalamic Melanin-Concentrating Hormone and Estrogen-Induced Weight Loss

R. Seeley, M. Schwartz, A. Matsumoto, 2000, The Journal of Neuroscience.

TESTOSTERONE REPLACEMENT IN HYPOGONADAL MEN: EFFECTS ON OBSTRUCTIVE SLEEP APNOEA, RESPIRATORY DRIVES, AND SLEEP

Kathryn A. Lee, D. Pierson, E. Giblin, 1985, Clinical endocrinology.

Androgen Treatment of Male Hypogonadism

A. Matsumoto, 2007 .

Mechanism of action of bolandiol (19-nortestosterone-3β,17β-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities

C. Coss, A. Matsumoto, S. Page, 2010, The Journal of Steroid Biochemistry and Molecular Biology.

Cross-sectional and longitudinal analysis of age-associated changes in body composition of male Brown Norway rats: association of serum leptin levels with peripheral adiposity.

A. Matsumoto, B. Marck, L. Smith, 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.

Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels

M. Thompson, S. Heckbert, N. Smith, 2018, PloS one.

Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study.

P. Schellhammer, C. Roehrborn, M. Resnick, 2000, The Journal of urology.

Immature spermatids are not p in semen from men who are receiving androgen-based co

Y. Zhengwei, A. Matsumoto, W. Bremner, 1998 .

Reference intervals for free testosterone in adult men measured using a standardized equilibrium dialysis procedure

B. Yeap, Ravi Jasuja, W. Dhillo, 2022, Andrology.

Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants

P. Nelson, R. Vessella, S. Plymate, 2011, Clinical Cancer Research.

Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis.

D. Siscovick, E. Boyko, E. Whitsel, 2001, The American journal of medicine.

Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia.

D. Tindall, C. Roehrborn, G. Andriole, 2004, The Journal of urology.

Chapter 19 – Testicular Disorders

A. Matsumoto, W. Bremner, 2011 .

Suboptimal osteoporosis evaluation and treatment in older men with and without additional high-risk factors for fractures

E. Phelan, A. Matsumoto, B. Anawalt, 2019, Journal of Investigative Medicine.

Induction of stereotypy in dopamine-deficient mice requires striatal D1 receptor activation

R. Palmiter, D. Dorsa, A. Matsumoto, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.

Frederick C W Wu, S. Bhasin, H. Hodis, 2018, The Journal of clinical endocrinology and metabolism.

Evidence for activation of the central nervous system-pituitary mechanism for gonadotropin secretion at the time of puberty in the male rat.

W J Bremner, D. Dorsa, A. Matsumoto, 1986, Endocrinology.

Noradrenaline is essential for mouse fetal development

R. Palmiter, A. Matsumoto, S. Thomas, 1995, Nature.

Endocrinology of the hypothalamic-pituitary-testicular axis with particular reference to the hormonal control of spermatogenesis.

A. Matsumoto, W. Bremner, 1987, Bailliere's clinical endocrinology and metabolism.

Hormonal therapy of male hypogonadism.

A. Matsumoto, 1994, Endocrinology and metabolism clinics of North America.

Stimulation of sperm production by human luteinizing hormone in gonadotropin-suppressed normal men.

A. Matsumoto, W. Bremner, C. A. Paulsen, 1984, The Journal of clinical endocrinology and metabolism.

Reinitiation of sperm production in gonadotropin-suppressed normal men by administration of follicle-stimulating hormone.

A. Matsumoto, W. Bremner, C. A. Paulsen, 1983, The Journal of clinical investigation.

Stimulation of serum inhibin concentrations by gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism.

H. Burger, A. Matsumoto, W. Bremner, 1988, The Journal of clinical endocrinology and metabolism.

Follicle-stimulating hormone is required for quantitatively normal inhibin secretion in men.

H. Burger, A. Matsumoto, W. Bremner, 1988, The Journal of clinical endocrinology and metabolism.

Gonadotropin Control of Spermatogenesis in Man: Studies of Gonadotropin Administration in Spontaneous and Experimentally Induced Hypogonadotropic States a

A. Matsumoto, W. Bremner, C. A. Paulsen, 1984, Annals of the New York Academy of Sciences.

Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonadotropic hypogonadism.

S. Bhasin, A. Matsumoto, P. Snyder, 2009, Fertility and sterility.

Elevated serum follicle-stimulating hormone levels in men with normal seminal fluid analyses.

A. Matsumoto, W. Bremner, C. A. Paulsen, 1983, Fertility and sterility.

Follicle Stimulating Hormone and the Control of Spermatogenesis and Inhibin Secretion in Men

A. Matsumoto, W. Bremner, 1992 .

Stimulation of sperm production by human chorionic gonadotropin after prolonged gonadotropin suppression in normal men.

A. Matsumoto, W. Bremner, A. M. Matsumoto, 1985, Journal of andrology.

The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate.

A. Matsumoto, W. Bremner, S. Plymate, 1987, The Journal of clinical endocrinology and metabolism.

The physiological significance of pulsatile LHRH secretion in man: gonadotrophin responses to physiological doses of pulsatile versus continuous LHRH administration.

A. Matsumoto, W. Bremner, K. M. Gross, 1991, International journal of andrology.

Increased frequency of pulsatile luteinizing hormone-releasing hormone administration selectively decreases follicle-stimulating hormone levels in men with idiopathic azoospermia.

A. Matsumoto, W. Bremner, R. Berger, 1986, Fertility and sterility.

Testicular fine-needle aspiration for the assessment of intratesticular hormone concentrations

A. Matsumoto, W. Bremner, J. Amory, 2015, Asian journal of andrology.

Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial.

K. Herbst, A. Matsumoto, W. Bremner, 2005, Journal of andrology.

Relative roles of follicle-stimulating hormone and luteinizing hormone in the control of inhibin secretion in normal men.

H. Burger, A. Matsumoto, W. Bremner, 1988, The Journal of clinical investigation.

Impact of male hormonal contraception on prostate androgens and androgen action in healthy men: a randomized, controlled trial.

P. Nelson, J. Wright, D. Lin, 2012, The Journal of clinical endocrinology and metabolism.

Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment.

A. Matsumoto, W. Bremner, D. Robertson, 2004, The Journal of clinical endocrinology and metabolism.

Harmonized Reference Ranges for Circulating Testosterone Levels in Men of Four Cohort Studies in the United States and Europe

T. Travison, J. Kaufman, T. Fiers, 2017, The Journal of clinical endocrinology and metabolism.

Spontaneous and Experimentally Induced Hypogonadotropic Statesa

A. Matsumoto, W. Bremner, C. A. Paulsen, 2006 .

Endocrine control of human spermatogenesis.

A. Matsumoto, W. Bremner, 1989, Journal of steroid biochemistry.

The luteinizing hormone-releasing hormone pulse generator in men: abnormalities and clinical management.

A. Matsumoto, W. Bremner, C. B. Sheckter, 1990, American journal of obstetrics and gynecology.

Testosterone supplementation improves spatial and verbal memory in healthy older men

S. Asthana, E. Peskind, S. Plymate, 2001, Neurology.

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.

V. Montori, S. Bhasin, R. Swerdloff, 2010, The Journal of clinical endocrinology and metabolism.

Evidence for decreased luteinizing hormone-releasing hormone pulse frequency in men with selective elevations of follicle-stimulating hormone.

A. Matsumoto, W. Bremner, M. B. Southworth, 1985, The Journal of clinical endocrinology and metabolism.

Serum 17-hydroxyprogesterone strongly correlates with intratesticular testosterone in gonadotropin-suppressed normal men receiving various dosages of human chorionic gonadotropin.

A. Matsumoto, W. Bremner, A. Coviello, 2008, Fertility and sterility.

Chronic Human Chorionic Gonadotropin Administration in Normal Men: Evidence that Follicle-Stimulating Hormone Is Necessary for the Maintenance of Quantitatively Normal Spermatogenesis in Man

A. Matsumoto, W. Bremner, A. Karpas, 1987 .

Daily testosterone and gonadotropin levels are similar in azoospermic and nonazoospermic normal men administered weekly testosterone: implications for male contraceptive development.

A. Matsumoto, W. Bremner, J. Amory, 2001, Journal of andrology.

Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1−/− mice

Kan Ding, Arti Gaur, A. Gaur, 2003, Nature Genetics.

Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy

S. Beresford, A. Matsumoto, S. Lee, 2005, Hepatology.

Daily Melatonin Administration to Middle-Aged Male Rats Suppresses Body Weight, Intraabdominal Adiposity, and Plasma Leptin and Insulin Independent of Food Intake and Total Body Fat1.

A. Matsumoto, C. Wilkinson, S. Yellon, 2000, Endocrinology.

Printed in U.S.A. Copyright © 2000 by The Endocrine Society Daily Melatonin Administration to Middle-Aged Male Rats Suppresses Body Weight, Intraabdominal Adiposity, and Plasma Leptin and Insulin Independent of Food Intake and Total Body Fat*

A. Matsumoto, C. Wilkinson, S. Yellon, 2022 .

Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men.

A. Iranmanesh, A. Dobs, R. Swerdloff, 2000, The Journal of clinical endocrinology and metabolism.

Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat.

E. Boyko, W. Fujimoto, A. Matsumoto, 2004, Diabetes care.

Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived Xenografts.

P. Nelson, E. Corey, M. Schweizer, 2020, European urology.

Prostate Cancer Characteristics Associated with Response to Pre-Receptor Targeting of the Androgen Axis

P. Nelson, R. Vessella, C. Higano, 2014, PloS one.

Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer.

P. Nelson, M. Gleave, L. Fazli, 2007, Cancer research.

The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development.

R. Hammer, S. McKnight, D. Russell, 1998, Genes & development.

Targeted androgen pathway suppression in localized prostate cancer: a pilot study.

P. Kantoff, P. Nelson, W. Ellis, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trial.

P. Nelson, J. Wright, D. Lin, 2011, The Journal of clinical endocrinology and metabolism.

Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study.

J. Richie, M. Loda, P. Kantoff, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Reappraisal of Testosterone's Binding in Circulation: Physiological and Clinical Implications.

Frederick C W Wu, S. Bhasin, Ravi Jasuja, 2017, Endocrine reviews.

Reduced gonadotropin-releasing hormone gene expression with fasting in the male rat brain.

A. Matsumoto, D. Gruenewald, 1993, Endocrinology.

Serum testosterone assays--accuracy matters.

A. Matsumoto, W. Bremner, 2004, The Journal of clinical endocrinology and metabolism.

AGING, DIABETES, AND FALLS.

A. Vinik, J. Morley, A. Matsumoto, 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Cognitive effects of short-term manipulation of serum sex steroids in healthy young men.

S. Craft, M. Cherrier, K. Herbst, 2002, The Journal of clinical endocrinology and metabolism.

A. Matsumoto, D. Gruenewald, B. Marck, 2000, Journal of andrology.

Modulation of luteinizing hormone pulse amplitude by the frequency of luteinizing hormone-releasing hormone stimulation and by testosterone in castrated, hypothalamic-lesioned male rats.

A. Matsumoto, W. Bremner, E. Petrie, 1988, Biology of reproduction.

Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels.

C. Lewis, T. Gill, J. Cauley, 2016, The Journal of clinical endocrinology and metabolism.

Low Testosterone Associated With Obesity and the Metabolic Syndrome Contributes to Sexual Dysfunction and Cardiovascular Disease Risk in Men With Type 2 Diabetes

G. Jackson, A. Traish, Christina Wang, 2011, Diabetes Care.

External beam radiation therapy and abiraterone in men with localized prostate cancer: safety and effect on tissue androgens.

K. Russell, B. Kurland, J. Liao, 2015, International journal of radiation oncology, biology, physics.

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline.

V. Montori, S. Bhasin, R. Swerdloff, 2006, The Journal of clinical endocrinology and metabolism.

Tumor response and adaptation to CYP17 inhibition in prostate cancer: Induction of steroidogenesis and androgen receptor splice variants.

S. Plymate, A. Matsumoto, E. Mostaghel, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Defective Motor Behavior and Neural Gene Expression in RIIβ-Protein Kinase A Mutant Mice

J. Wehner, M. Qi, R. Idzerda, 1998, The Journal of Neuroscience.

Testosterone, Dihydrotestosterone, Sex Hormone–Binding Globulin, and Incident Diabetes Among Older Men: The Cardiovascular Health Study

D. Siscovick, L. Djoussé, J. Ix, 2016, The Journal of clinical endocrinology and metabolism.

Effects of Testosterone Treatment in Older Men.

S. Resnick, C. Lewis, T. Gill, 2016, The New England journal of medicine.

Lower serum testosterone concentrations are associated with a higher incidence of dementia in men: The UK Biobank prospective cohort study

G. Hankey, C. Ohlsson, A. Dobs, 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Serum androgens and risk of atrial fibrillation in older men: The Cardiovascular Health Study

R. Kronmal, S. Heckbert, L. Lange, 2018, Clinical cardiology.

Testosterone Supplementation Therapy for Older Men: Potential Benefits and Risks

A. Matsumoto, D. Gruenewald, 2003, Journal of the American Geriatrics Society.

Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study.

A. Araujo, J. Mckinlay, C. Longcope, 2004, The Journal of clinical endocrinology and metabolism.

Inhibitory Interplay of SULT2B1b Sulfotransferase with AKR1C3 Aldo-keto Reductase in Prostate Cancer.

Yidong Chen, P. Osmulski, M. Gaczynska, 2020, Endocrinology.

Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial

C. Lewis, T. Gill, J. Cauley, 2017, JAMA internal medicine.

Suppression of hypothalamic pro‐opiomelanocortin (POMC) gene expression by daily melatonin supplementation in aging rats

A. Matsumoto, B. Marck, S. Yellon, 2003, Journal of pineal research.

A. Matsumoto, W. Bremner, D. Clifton, 1988, Journal of gerontology.

Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.

A. Matsumoto, W. Bremner, J. Amory, 2005, The Journal of clinical endocrinology and metabolism.

Erratum: Testosterone therapy in adult men with androgen deficiency syndromes: An endocrine society clinical practice guideline (Journal of Clinical Endocrinology and Metabolism (2006) 91, (1995-2000))

V. Montori, S. Bhasin, R. Swerdloff, 2006 .

Endocrine Society Clinical Practice Guideline Testosterone Therapy in Men with Androgen Deficiency Syndromes: An

V. Montori, A. Matsumoto, G. Cunningham, 2010 .

A. Matsumoto, D. Gruenewald, B. Marck, 2000 .

Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment

S. Resnick, C. Lewis, T. Gill, 2017, JAMA.

Acceptability of a combination testosterone gel and depomedroxyprogesterone acetate male contraceptive regimen.

A. Matsumoto, W. Bremner, J. Amory, 2007, Contraception.

The role of aromatization in testosterone supplementation

E. Peskind, S. Craft, M. Cherrier, 2005, Neurology.

Low serum testosterone and mortality in male veterans.

D. Kivlahan, A. Matsumoto, M. Shores, 2006, Archives of internal medicine.

Long-term effects of dimethandrolone 17β-undecanoate and 11β-methyl-19-nortestosterone 17β-dodecylcarbonate on body composition, bone mineral density, serum gonadotropins, and androgenic/anabolic activity in castrated male rats.

A. Matsumoto, B. Marck, B. Attardi, 2011, Journal of andrology.

Andropause: clinical implications of the decline in serum testosterone levels with aging in men.

A. Matsumoto, 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.

Cortisol levels and measures of body composition in middle‐aged and older men

T. Travison, A. Araujo, J. Mckinlay, 2007, Clinical endocrinology.

Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial

H. Cohen, S. Resnick, S. Anton, 2017, JAMA internal medicine.

Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone

M. Budoff, C. Lewis, T. Gill, 2017, JAMA.

Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trials.

S. Resnick, C. Lewis, T. Gill, 2015, The Journal of clinical endocrinology and metabolism.

Title Erratum : The Testosterone Trials : Seven coordinated trials of testosterone treatment in elderly men

M. Budoff, S. Resnick, C. Lewis, 2014 .

Serum testosterone is inversely, and sex hormone-binding globulin directly, associated with all-cause mortality in men.

C. Reid, G. Hankey, C. Ohlsson, 2020, The Journal of clinical endocrinology and metabolism.

Restoration of Norepinephrine and Reversal of Phenotypes in Mice Lacking Dopamine β‐Hydroxylase

R. Palmiter, A. Matsumoto, B. Marck, 1998, Journal of neurochemistry.

Lessons From the Testosterone Trials

H. Cohen, M. Budoff, S. Resnick, 2018, Endocrine reviews.

Summary of Recommendations 1 . 1 Diagnosis and evaluation of patients with suspected androgen deficiency

V. Montori, R. Swerdloff, A. Matsumoto, 2010 .

Increased incidence of diagnosed depressive illness in hypogonadal older men.

B. Felker, D. Kivlahan, A. Matsumoto, 2004, Archives of general psychiatry.

Obstructive sleep apnea syndrome induced by testosterone administration.

D. Pierson, E. Giblin, A. Matsumoto, 1983, The New England journal of medicine.

Blunted hypothalamic neuropeptide gene expression in response to fasting, but preservation of feeding responses to AgRP in aging male Brown Norway rats.

A. Matsumoto, B. Marck, T. Wolden‐Hanson, 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

Association Between Testosterone Treatment and Risk of Incident Cardiovascular Events Among US Male Veterans With Low Testosterone Levels and Multiple Medical Comorbidities

M. Thompson, S. Heckbert, N. Smith, 2021, Journal of the American Heart Association.

Distribution and regulation of galanin receptor 1 messenger RNA in the forebrain of wild type and galanin-transgenic mice

J. Hohmann, R. Steiner, A. Matsumoto, 2003, Neuroscience.

Tissue selectivity of the anabolic steroid, 19-nor-4-androstenediol-3beta,17beta-diol in male Sprague Dawley rats: selective stimulation of muscle mass and bone mineral density relative to prostate mass.

A. Matsumoto, B. Marck, S. Page, 2008, Endocrinology.

CLINICAL PRACTICE GUIDELINE Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline

V. Montori, S. Bhasin, R. Swerdloff, 2010 .

Troglitazone treatment of aging Brown Norway rats improves food intake and weight gain after fasting without increasing hypothalamic NPY gene expression

A. Matsumoto, B. Marck, T. Wolden‐Hanson, 2002, Experimental Gerontology.

Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity[S]

T. Vaisar, A. Matsumoto, J. Heinecke, 2012, Journal of Lipid Research.

Effect of testosterone replacement on measures of mobility in older men with mobility limitation and low testosterone concentrations: secondary analyses of the Testosterone Trials.

C. Lewis, T. Gill, J. Cauley, 2018, The lancet. Diabetes & endocrinology.

Leptin Levels are Appropriate for Body Mass Index in Older Men Who Experience Involuntary Weight Loss

A. Matsumoto, R. Pearlman, M. Yukawa, 2002, Journal of the American Geriatrics Society.

Characterization of verbal and spatial memory changes from moderate to supraphysiological increases in serum testosterone in healthy older men

E. R. Peskind, E. Peskind, S. Craft, 2007, Psychoneuroendocrinology.

Recruitment and Screening for the Testosterone Trials.

S. Resnick, C. Lewis, T. Gill, 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.

A randomized, double-blind, placebo-controlled study of testosterone treatment in hypogonadal older men with subthreshold depression (dysthymia or minor depression).

D. Kivlahan, A. Matsumoto, M. Shores, 2009, The Journal of clinical psychiatry.

Low Testosterone Is Associated with Decreased Function and Increased Mortality Risk: A Preliminary Study of Men in a Geriatric Rehabilitation Unit

D. Kivlahan, A. Matsumoto, D. Gruenewald, 2004, Journal of the American Geriatrics Society.

New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men.

A. Dobs, Christina Wang, R. Swerdloff, 2004, The Journal of clinical endocrinology and metabolism.

Testosterone Treatment of Men With Mild Cognitive Impairment and Low Testosterone Levels

M. Cherrier, J. Shofer, A. Matsumoto, 2015, American journal of Alzheimer's disease and other dementias.

Androgens In Men Study (AIMS): protocol for meta-analyses of individual participant data investigating associations of androgens with health outcomes in men

T. Travison, D. Couper, P. Cawthon, 2020, BMJ Open.

PROGRESS IN GERIATRICS Testosterone Supplementation Therapy for Older Men : Potential Benefits and Risks

A. Matsumoto, D. Gruenewald, 2002 .

A. Matsumoto, D. Gruenewald, 1991, Endocrinology.

Acute selective withdrawal of testosterone negative feedback increases luteinizing hormone secretion without altering hypothalamic catecholaminergic neuronal activity.

A. Matsumoto, J. Liebmann, 1990, Endocrinology.

Neuroendocrine Correlates of Aging in the Male

R. Steiner, D. Dorsa, A. Matsumoto, 1986 .

The Brown Norway rat as a model of male reproductive aging: evidence for both primary and secondary testicular failure.

A. Matsumoto, D. Gruenewald, D. Hess, 1994, Journal of gerontology.

REPRODUCTIVE NEUROENDOCRINOLOGY OF THE AGING MALE12

A. Matsumoto, W. Bremner, A. Karpas, 1983 .

Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment

S. Asthana, E. Peskind, S. Craft, 2005, Neurology.

Testosterone, Dihydrotestosterone, Bone Density, and Hip Fracture Risk among Older Men: The Cardiovascular Health Study.

J. Robbins, H. Fink, P. Bůžková, 2020, Metabolism: clinical and experimental.

A. Matsumoto, D. Gruenewald, B. Marck, 1994, Endocrinology.

Relationship between testosterone supplementation and insulin-like growth factor-I levels and cognition in healthy older men

A. Haley, S. Asthana, E. Peskind, 2004, Psychoneuroendocrinology.

Lack of seasonal variation in serum sex hormone levels in middle-aged to older men in the Boston area.

J. Mckinlay, A. Matsumoto, D. Brambilla, 2007, The Journal of clinical endocrinology and metabolism.

Alteration of neurotransmitter phenotype in noradrenergic neurons of transgenic mice.

R. Palmiter, G. Hoyle, R. Palmiter, 1992, Molecular endocrinology.

Depression of hypercapnic ventilatory drive by testosterone in the sleeping infant primate.

A. Matsumoto, M. Hlastala, M. Emery, 1994, Journal of applied physiology.

The importance of signal pattern in the transmission of endocrine information: pituitary gonadotropin responses to continuous and pulsatile gonadotropin-releasing hormone.

M. Soules, A. Matsumoto, W. Bremner, 1991, The Journal of clinical endocrinology and metabolism.

Biomarkers and Non-Calcified Coronary Artery Plaque Progression in Older Men Treated with Testosterone.

C. Lewis, J. Cauley, K. Ensrud, 2019, The Journal of clinical endocrinology and metabolism.

Testosterone Replacement in Men with Age-Related Low Testosterone: What Did We Learn From The Testosterone Trials?

A. Matsumoto, 2019, Current opinion in endocrine and metabolic research.

Testosterone and dihydrotestosterone and incident ischaemic stroke in men in the Cardiovascular Health Study

A. Arnold, W. Longstreth, C. Hirsch, 2014, Clinical endocrinology.

Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study.

W. Longstreth, A. Arnold, C. Hirsch, 2014, The Journal of clinical endocrinology and metabolism.

Testosterone administration to normal men decreases truncal and total body fat

K. Herbst, A. Matsumoto, W. Bremner, 1996 .

Associations of Serum Testosterone and Sex Hormone–Binding Globulin With Incident Cardiovascular Events in Middle-Aged to Older Men

G. Hankey, C. Ohlsson, A. Dobs, 2021, Annals of Internal Medicine.

Excessive testicular progesterone secretion in aged male Fischer 344 rats: a potential cause of age-related gonadotropin suppression and confounding variable in aging studies.

A. Matsumoto, D. Gruenewald, C. Wilkinson, 1992, Journal of gerontology.

Dutasteride reduces prostate size and prostate specific antigen in older hypogonadal men with benign prostatic hyperplasia undergoing testosterone replacement therapy.

A. Matsumoto, M. Dighe, B. Marck, 2011, The Journal of urology.

Sociodemographic, lifestyle and medical influences on serum testosterone and sex hormone–binding globulin in men from UK Biobank

C. Reid, C. Ohlsson, A. Dobs, 2020, Clinical endocrinology.

Does testosterone supplementation improve health and function in elderly men?

A. Matsumoto, J. Amory, S. Page, 2008, Nature Clinical Practice Endocrinology &Metabolism.

Patient information page from The Hormone Foundation. Patient guide to testosterone therapy in adult men with androgen deficiency syndromes.

S. Bhasin, A. Matsumoto, 2010, The Journal of clinical endocrinology and metabolism.

Aging and androgens: Physiology and clinical implications.

A. Matsumoto, B. Anawalt, 2022, Reviews in endocrine & metabolic disorders.

Development and Validation of Quality Measures for Testosterone Prescribing.

Varsha G. Vimalananda, A. Matsumoto, J. Reisman, 2023, Journal of the Endocrine Society.

Modulation of pulsatile gonadotropin secretion by testosterone in man.

A. Matsumoto, W. Bremner, A. M. Matsumoto, 1986, The Journal of clinical endocrinology and metabolism.

Testosterone accumulation in prostate cancer cells is enhanced by facilitated diffusion.

L. True, A. Kaipainen, C. Morrissey, 2019, The Prostate.

Factors Associated With Circulating Sex Hormones in Men

T. Travison, G. Hankey, D. Couper, 2023, Annals of Internal Medicine.

Evidence that noradrenergic activity does not mediate the inhibition of luteinizing hormone secretion caused by vasoactive intestinal peptide

R. Steiner, A. Matsumoto, M. J. Alexander, 1988, Brain Research.

Neonatal 6-Hydroxydopamine Administration to Mice Is Fatal

R. Palmiter, A. Matsumoto, M. Szczypka, 2003, Developmental Neuroscience.

Effects of testosterone therapy in older men.

A. Matsumoto, S. Page, 2008, JAMA.

Faculty Opinions recommendation of Sympathetic β1-adrenergic signaling contributes to regulation of human bone metabolism.

A. Matsumoto, 2018, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

Cross-sectional and longitudinal analysis of age-associated changes in body composition of male Brown Norway rats: association of serum leptin levels with peripheral adiposity.

A. Matsumoto, B. Marck, TamiWolden-Hanson, 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.

Neoadjuvant Enzalutamide Prior to Prostatectomy

P. Kantoff, P. Nelson, G. Haas, 2016, Clinical Cancer Research.

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.

V. Montori, S. Bhasin, R. Swerdloff, 2010, The Journal of clinical endocrinology and metabolism.

Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study.

W. Longstreth, A. Arnold, C. Hirsch, 2014, The Journal of clinical endocrinology and metabolism.

Preliminary Evaluation of an Order Template to Improve Diagnosis and Testosterone Therapy of Hypogonadism in Veterans.

A. Matsumoto, C. Song, Ethan H K Nguyen, 2021, Federal practitioner : for the health care professionals of the VA, DoD, and PHS.

Performance of total testosterone measurement to predict free testosterone for the biochemical evaluation of male hypogonadism.

J. Hotaling, A. Matsumoto, T. Walsh, 2012, The Journal of urology.

Testosterone Replacement Therapy in Men

A. Matsumoto, 2016 .

Evaluation of Men With Hypogonadotropic Hypogonadism: Clinical, Laboratory, and Imaging

A. Matsumoto, 2015 .

Factors Associated With Circulating Sex Hormones in Men

T. Travison, G. Hankey, D. Couper, 2023, Annals of Internal Medicine.

P. Nelson, E. Corey, M. Schweizer, 2020, European urology.

Long-Term Effects of Dimethandrolone 17Beta-Undecanoate (DMAU) and 11Beta-Methyl-19-Nortestosterone 17Beta-Dodecylcarbonate (11Beta-MNTDC) on Body Composition, Bone Mineral Density (BMD), Serum Gonadotropins, and Androgenic/Anabolic Activity in Castrated Male Rats.

A. Matsumoto, B. Marck, B. Attardi, 2009 .

CROSS-SECTIONAL AND LONGITUDINAL ANALYSIS OF AGE-ASSOCIATED CHANGES IN BODY COMPOSITION OF MALE BROWN NORWAY RATS : ASSOCIATION OF SERUM LEPTIN LEVELS WITH PERIPHERAL ADIPOSITY. COMMENTARY. AUTHORS' REPLY

P. Garry, H. Perry, J. Morley, 1999 .